XML 173 R79.htm IDEA: XBRL DOCUMENT
v3.20.4

Collaboration Agreements - Chiesi Agreement Total Transaction Price to the Identified Performance Obligations (Details) $ in Thousands | Dec. 31, 2020 USD ($)
--- | ---
Research and Development Arrangement, Contract to Perform for Others [Line Items] |
Remaining performance obligations | $ 87,225
Chiesi agreement |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |
Remaining performance obligations | 42,496
Chiesi agreement | Upfront payment |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |
Remaining performance obligations | 25,000
Chiesi agreement | Research and development |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |
Remaining performance obligations | 17,496
Chiesi agreement | Chiesi Agreement transaction price |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |
Remaining performance obligations | 42,496
Chiesi agreement | Remaining unsatisfied performance obligation |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |
Remaining performance obligations | $ 42,293

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ResearchAndDevelopmentFundingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ChiesiAgreementTransactionPriceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_RemainingUnsatisfiedPerformanceObligationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |